Druggability Evaluation Technology Platform

Druggability Evaluation Technology Platform

The company has a comprehensive and rapid peptide druggability evaluation platform, including a peptide drug design and discovery platform, a peptide synthesis platform, systematic preclinical pharmaceutical research, pharmacodynamics research, pharmacokinetics research platforms, an SPF-grade animal facility and a GMP-standard cell facility, providing comprehensive and rapid peptide druggability evaluation.

 Anji Biotech possesses various cell models;

Animal models:

• Diabetes: STZ model, KK-Ay model, db/db model
• Tumor models: various nude mouse xenograft models, mouse melanoma models
• Rheumatoid arthritis models: collagen model, adjuvant model
• Fibrosis models: pulmonary fibrosis, hepatic fibrosis and renal fibrosis models
• Analgesia models: hot plate model, acetic acid writhing model, von Frey filament model
• Depression models: mouse behavioral despair model
• Inflammation models: ear edema, cotton pellet granuloma model, carrageenan

Pharmacokinetics research:

• ELISA methodology development
• In vivo half-life studies in small animals
• Bioavailability studies
• Tissue distribution studies
• Drug excretion experiments